Raltegravir in Virologically Suppressed Overweight WomenRaltegravir in Virologically Suppressed Overweight Women

When women with central adiposity switch to RAL from a PI or NNRTI, they could experience a significant decrease in sCD14. HIV Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news